| Outcome Measures: |
Primary: Pulse wave velocity, Change from baseline carotid-femoral pulse wave velocity at 7 days. Using a PulsePen tonometer by DiaTechne., 7 days | Secondary: Fasting plasma glucose, Change from baseline, using the BioSystems® Glucose Oxidase / Peroxidase kit; in an automated clinical chemistry analysis equipment brand XL-100Erba, 7 days|Total cholesterol, Change from baseline, using the BioSystems® Glucose Oxidase / Peroxidase kit., 7 days|Triglycerides, Change from baseline, using the BioSystems® Glycerol phosphate Oxidase / Peroxidase kit., 7 days|High-density lipoprotein cholesterol, Change from baseline, using the BioSystems® Direct / Detergent HDL kit, 7 days|Low-density lipoprotein cholesterol, Change from baseline, using the BioSystems® Cholesterol Oxidase / Peroxidase kit, 7 days|Creatinine, Change from baseline, using the BioSystems® kit Modified Jaffe's no deproteinization, 7 days|Blood pressure, Change from baseline, using an OMRON calibrated electronic digital sphygmomanometer model HEM 907 XL. The patient will remain seated in a chair resting his back on the backrest, with a minimum rest of 5 minutes, The average of 3 measurements such as BP will be taken, 7 days
|
